Waypoint Wealth Counsel’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.3K Buy
11,290
+10,340
+1,088% +$167K 0.05% 221
2025
Q4
$16.4K Buy
+950
New +$18.4K 0.01% 285

Other funds holding AGL

Waypoint Wealth Counsel's AGL Position: Q1 2026 in Review

Waypoint Wealth Counsel increased its Agilon Health (AGL) stake by 1,088% in Q1 2026, buying an estimated $167K and bringing the position to 11,290 shares worth $89.3K. The position accounts for 0.05% of the portfolio, ranked #221.

Waypoint Wealth Counsel first reported a position in AGL in Q4 2025 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Waypoint Wealth Counsel held 11,290 shares of Agilon Health worth $89.3K as of Q1 2026.
  • Waypoint Wealth Counsel bought 10,340 Agilon Health shares in Q1 2026, an estimated $167K.
  • Agilon Health made up 0.05% of Waypoint Wealth Counsel's portfolio in Q1 2026, its #221 holding.
  • Waypoint Wealth Counsel first reported a position in Agilon Health in Q4 2025 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Waypoint Wealth Counsel's 13F filing for Q1 2026, filed 23 Apr 2026.